Prevalence of lower urinary tract symptoms and self‐reported diagnosed ‘benign prostatic hyperplasia’, and their effect on quality of life in a community‐based survey of men in the UK
- 1 March 1999
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 83 (4), 410-415
- https://doi.org/10.1046/j.1464-410x.1999.00966.x
Abstract
Objectives To assess the prevalence of lower urinary tract symptoms (LUTS) in a community-based population in the UK, to measure the impact of these symptoms on quality of life and health status in men with self-reported ‘benign prostatic hyperplasia’ (‘BPH’), and to evaluate health-seeking behaviour in this population. Subjects and methods A postal survey was distributed to an age-stratified random sample of 1500 men aged 50 years or older from throughout England, Scotland and Wales. The self-administered survey included: demographic questions; the EuroQoL (EQ-5D) instrument, consisting of a health-status index questionnaire and a visual analogue scale (VAS) on which participants rated their current health status; the International Prostate Symptom Score (IPSS) questionnaire; and a questionnaire assessing the participants’ health-seeking behaviour and awareness of BPH. Results Responses to the survey were received from 1115 (74%) of the 1500 men. Overall, 41% (450/ 1088) had an IPSS of ≥8, indicating moderate-to-severe LUTS, yet only 196 men (18%) reported that they had been diagnosed with ‘BPH’. Both quality of life (as measured by the EQ-5D) and general health status (as measured by the VAS) decreased as urinary symptom severity increased, and the greater the severity, the more men who reported a problem with mobility, self-care, usual activity, pain/discomfort, and anxiety/depression (the five domains of the EQ-5D). The possibility of symptoms worsening appeared to be the key determinant in the respondents’ decisions to consult a medical professional for their LUTS. Less than 11% of the respondents were aware of the availability of specific prescription drug therapies or surgical options for the treatment of ‘BPH’. The most common first treatment strategy for those consulting for symptoms was watchful waiting (34%), followed by surgery (30%) and prescription drugs (21%). Conclusions Moderate-to-severe LUTS were relatively common in this UK population of men over the age of 50, yet relatively few had been diagnosed with ‘BPH’. As LUTS adversely affect quality of life, improved treatment options and increased public awareness of BPH and LUTS are needed to combat a problem facing the growing number of elderly men in the population.Keywords
This publication has 20 references indexed in Scilit:
- Benign prostatic hyperplasia in an unselected community-based population: a survey of urinary symptoms, bothersomeness and prostatic enlargementBritish Journal of Urology, 1996
- Natural history of benign prostatic hyperplasia: Appropriate case definition and estimation of its prevalence in the communityUrology, 1995
- Benign Prostatic Hyperplasia — Medical and Minimally Invasive Treatment OptionsThe New England Journal of Medicine, 1995
- ‘Prostate‐related symptoms’ in Canadian men 50 years of age or older: prevalence and relationships among symptomsBritish Journal of Urology, 1994
- Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaireQuality of Life Research, 1993
- Economic Burden of Treated Benign Prostatic Hyperplasia in the United KingdomBritish Journal of Urology, 1993
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Prevalence of Urinary Symptoms in Men Aged over 60British Journal of Urology, 1990